Treatment of T cell lymphoblastic lymphoma in children and adolescents: Israel society of pediatric hematology oncology retrospective study

Israel Medical Association Journal

Volumn 13, Issue 3, 2011, Pages 161-165

  Katz, Ofrat Beyar ^a   Barak, Ayelet Ben ^a   Abrahami, Gali ^b   Arad, Nira ^a   Burstein, Yoav ^c   Dvir, Rina ^c   Fischer, Salvador ^b   Kapelushnik, Joseph ^d   Kaplinsky, Haim ^e   Toren, Amos ^e   Vilk Revel, Shoshana ^e   Weintraub, Michael ^f   Yaniv, Isaac ^b   Linn, Shai ^a   Futerman, Boris ^a   Weyl Ben Arush, Myriam ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Adolescents; Chemotherapy; Children; Lymphoblastic lymphoma; T cell

Indexed keywords

ANTINEOPLASTIC AGENT; CD45 ANTIGEN;

ACUTE PANCREATITIS; ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; BONE MARROW APLASIA; BRAIN RADIATION; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CEREBRAL SINUS THROMBOSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FEVER; HUMAN; ISRAEL; LUNG HEMORRHAGE; LYMPHOBLASTOMA; MALE; OVERALL SURVIVAL; PANCREAS PSEUDOCYST; PRESCHOOL CHILD; PROGNOSIS; RETROSPECTIVE STUDY; SEPTIC SHOCK; TONIC CLONIC SEIZURE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; ISRAEL; NEOPLASM STAGING; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79954506692     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratifed for biologic subtypes and stage - a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol 1995; 13: 359-372.
2. Tubergen DG, Krailo MD, Meadows AT, et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol 1995; 13: 1368-1376.
3. Link MP, Shuster JJ, Donaldson SS, Berard CW, Murphy SB. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med 1997; 337: 1259-1266.
4. Mora J, Filippa DA, Qin J, Wollner N. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center. Cancer 2003; 98: 1283-1291.
5. Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 2000; 95: 416-421.
6. Pillon M, Piglione M, Garaventa A, et al. Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer 2009; 53: 953-959.
7. Uyttebroeck A, Suciu S, Laureys G, et al. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. Eur J Cancer 2008; 44: 840-846.
8. Eldar AH, Futerman B, Abrahami G, et al. Burkitt lymphoma in children: the Israeli experience. J Pediatr Hematol Oncol 2009; 31: 428-436.
9. Coustan-Smith E, Sandlund JT, Perkins SL, et al. Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group. J Clin Oncol 2009; 27: 3533-3539.